TrialPloS one2011
Excessive biologic response to IFNβ is associated with poor treatment response in patients with multiple sclerosis.
Richard A Rudick et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
20 papers cite it
this paperpooled itcites it